South African pharmaceuticals giant Adcock Ingram delivered a “resilient performance” in the financial year ended June 30, which CEO Andy Hall said was despite the difficult operating environment, which was characterised by the continuing adverse impact of Covid-19, a tough economic environment and high levels of unemployment impacting on consumer spending. The group’s activities were regarded as essential services during the initial phases of the pandemic, and all business units continued to operate throughout all levels of lockdowns, while maintaining rigorous monitoring and evaluation of Covid-19 protocols to safeguard its employees and customers.
from Engineering News | Home https://ift.tt/2XVw2VE
